Flint LEADS to Focus on Early Cancer Detection, Access and Policy Action

FLINT, Mich. — The Flint LEADS events on Oct. 1–2 will bring together leaders from government, healthcare, research, industry and the community to examine how advances in cancer early detection can translate into affordable, practical and accessible care.

As cancer detection technologies continue to advance, Flint LEADS will focus on a critical challenge: making sure access keeps pace with innovation.

Rather than focusing only on what new technologies can detect, the discussions will examine what it takes to bring those advances into communities — including questions around affordability, coverage, reimbursement, navigation, implementation and long-term healthcare infrastructure.

The Oct. 1 Mayor’s Leadership Dinner will bring invited elected officials, healthcare executives, researchers and policy leaders together for a leadership discussion around early detection, community health investment and collaboration.

On Oct. 2, the Health Policy Conference will continue the conversation through structured discussions involving elected officials, healthcare leaders, researchers and industry partners. Topics are expected to include advances in early disease detection, healthcare investment, the role of local leadership and opportunities to move innovation toward real-world implementation.

Together, the two events are designed to address a larger question:

How can advances in cancer detection reach the people and communities that could benefit from them most?

Cancer Detection Is Entering a New Era

Cancer screening has long played an important role in finding certain cancers before symptoms appear. At the same time, emerging approaches such as multi-cancer early detection, liquid biopsy, genomic testing and other diagnostic innovations are expanding the national conversation around how and when cancer may be detected.

But advances in technology alone do not determine their impact.

New approaches also bring practical questions about who qualifies for testing, whether insurance will cover it, how providers will implement it, how patients will navigate follow-up care and whether new technologies will be affordable and available outside major medical and research centers.

Those questions are central to the Flint LEADS conversation.

The goal is not simply to discuss what science may make possible. It is to examine the healthcare systems, policies and partnerships needed to make earlier detection accessible in practice.

Why Flint?

Flint provides a real-world setting for examining those challenges.

Michigan health data show that 909 Genesee County residents died from cancer in 2024, with an age-adjusted cancer death rate of 161.6 deaths per 100,000 people. Cancer was the county’s second-leading cause of death that year, behind heart disease.

An analysis of Genesee County Medicare data used in the Flint LEADS initiative provides additional context. After adjusting for age, lung cancer prevalence was approximately 11% above the national comparison, while prostate cancer prevalence was approximately 13% above.

The analysis also found substantially higher healthcare utilization among beneficiaries carrying cancer indicators. Average annual Medicare spending was approximately $25,673 among cancer-flagged beneficiaries compared with $14,771 among beneficiaries without the five cancer flags examined in the analysis.

Those figures establish the health burden and urgency surrounding cancer in the region. They do not establish what caused individual cancer cases, whether earlier screening would have prevented those cases or how much spending could have been avoided through earlier detection.

Instead, the data help illustrate why communities such as Flint can play an important role in understanding what it takes to move early-detection innovation from scientific possibility into accessible care.

Building on Earlier Work in Flint

The October convening builds on earlier cancer prevention and early-detection work in Flint by the National Minority Quality Forum, or NMQF, and local partners.

Earlier this year, more than 200 Flint residents participated in the Flint Forward Community Town Hall and Free Mini Clinic. Residents connected with health screenings, prevention information, community resources and conversations about cancer risk and earlier detection.

The effort also marked the beginning of local enrollment in NMQF’s Community Health Biobank, a community-centered research initiative focused on understanding cancer detection and supporting appropriate follow-up care.

NMQF President and CEO Gary A. Puckrein, PhD, has described the broader Cancer Stage Shifting Initiative as an effort to move healthcare toward identifying disease earlier — including before symptoms appear — while pairing new approaches with community engagement, navigation and follow-up care.

Flint has also continued expanding its local public health infrastructure.

In July, the City of Flint established a new Division of Health Strategies and Advancement, designed to bring together data, research, policy development and community partnerships to identify health needs and develop locally focused strategies.

The city is continuing that work through an Early Detection Day Health & Wellness Event on Sept. 10, which will provide residents with mobile mammography, vaccinations, prevention education, health information and other community resources.

“Early detection and access to reliable health information can make a meaningful difference,” Flint Mayor Sheldon A. Neeley said when announcing the initiative.

From Innovation to Access

Flint LEADS will move this conversation from community outreach into a broader policy and healthcare leadership setting.

Technology developers can create new diagnostic capabilities. Healthcare systems and clinicians are responsible for delivering care. Payers and policymakers influence coverage, reimbursement and affordability. Community organizations can help residents understand available services, navigate healthcare systems and build trust.

No single part of that system can address the early-detection access challenge alone.

By bringing those perspectives into the same conversation, Flint LEADS is intended to examine how scientific advances can move toward practical implementation — and what policies, partnerships and investments may be needed along the way.

For policymakers and healthcare leaders, that means looking beyond whether a new test or technology exists.

It also means asking whether patients can afford it, whether insurers will cover it, whether clinicians can integrate it into existing care, whether appropriate follow-up is available and whether communities know how to access those services.

Innovation without access is not enough.

Turning Conversation Into Action

The Oct. 1–2 gathering is intended to serve as a catalyst rather than the finish line.

The broader opportunity is to identify where government, healthcare systems, researchers, industry and community organizations can work together on implementation, clinical opportunities, data infrastructure, healthcare investment and policy action.

For Flint, that creates an opportunity to contribute to a national discussion about the future of cancer detection while examining what implementation looks like in a real community.

As new approaches to detecting cancer continue to advance, the central challenge extends beyond what science can find.

The question is whether healthcare systems can build the coverage, affordability, navigation, clinical infrastructure and community partnerships necessary to ensure that innovation reaches the people who can benefit from it.

That is the challenge Flint LEADS is preparing to address.

Cancer detection is advancing. Access must keep pace.

Read More: Flint LEADS — Mayor’s Leadership Dinner & Health Policy Conference